Record Information
Version1.0
Creation Date2009-07-15 20:41:25 UTC
Update Date2026-03-26 22:46:37 UTC
Accession NumberCHEM002109
Identification
Common NameClodronate
ClassSmall Molecule
DescriptionClodronate is only found in individuals that have used or taken this drug. It is a diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. [PubChem]The bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a β-γ-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold Dictyostelium discoideum was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase.
Contaminant Sources
  • HMDB Contaminants - Urine
  • STOFF IDENT Compounds
  • T3DB toxins
Contaminant Type
  • Antihypocalcemic Agent
  • Antineoplastic Agent
  • Bisphosphonate
  • Bone Density Conservation Agent
  • Drug
  • Metabolite
  • Organic Compound
  • Organochloride
  • Osteoporosis Prophylactic
  • Synthetic Compound
Chemical Structure
Thumb
Synonyms
ValueSource
(Dichloro-phosphono-methyl)-phosphonic acidChEBI
(Dichloromethylene)bisphosphonic acidChEBI
(Dichloromethylene)diphosphonic acidChEBI
Acide clodroniqueChEBI
Acido clodronicoChEBI
Acidum clodronicumChEBI
ClodronsaeureChEBI
Dichloromethylene-1,1-bisphosphonic acidChEBI
Dichloromethylene-1,1-diphosphonic acidChEBI
Dichloromethylidene diphosphonateChEBI
(Dichloro-phosphono-methyl)-phosphonateGenerator
(Dichloromethylene)bisphosphonateGenerator
(Dichloromethylene)diphosphonateGenerator
Dichloromethylene-1,1-bisphosphonateGenerator
Dichloromethylene-1,1-diphosphonateGenerator
Dichloromethylidene diphosphonic acidGenerator
Clodronic acidGenerator
Acid, dichloromethanediphosphonicHMDB
BonefosHMDB
Clodronate disodiumHMDB
DichloromethanediphosphonateHMDB
Dichloromethylene diphosphonateHMDB
Acid, clodronicHMDB
Dichloromethane diphosphonateHMDB
Dichloromethylene biphosphonateHMDB
Diphosphonate, dichloromethaneHMDB
Biphosphonate, dichloromethyleneHMDB
Diphosphonate, dichloromethyleneHMDB
Disodium, clodronateHMDB
Sodium, clodronateHMDB
CL2MDPHMDB
Clodronate sodiumHMDB
Dichloromethanediphosphonic acidHMDB
DichloromethylenebisphosphonateHMDB
ClodronateChEBI
Chemical FormulaCH4Cl2O6P2
Average Molecular Mass244.892 g/mol
Monoisotopic Mass243.886 g/mol
CAS Registry Number10596-23-3
IUPAC Name[dichloro(phosphono)methyl]phosphonic acid
Traditional Nameclodronate
SMILESOP(O)(=O)C(Cl)(Cl)P(O)(O)=O
InChI IdentifierInChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)
InChI KeyACSIXWWBWUQEHA-UHFFFAOYSA-N
Chemical Taxonomy
Description belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassOrganic phosphonic acids and derivatives
Sub ClassBisphosphonates
Direct ParentBisphosphonates
Alternative Parents
Substituents
  • Bisphosphonate
  • Organophosphonic acid
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organophosphorus compound
  • Organochloride
  • Organohalogen compound
  • Alkyl halide
  • Alkyl chloride
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Biological Properties
StatusDetected and Not Quantified
OriginExogenous
Cellular Locations
  • Cytoplasm
  • Extracellular
  • Membrane
Biofluid LocationsNot Available
Tissue LocationsNot Available
PathwaysNot Available
Applications
Biological RolesNot Available
Chemical RolesNot Available
Physical Properties
StateSolid
AppearanceWhite powder.
Experimental Properties
PropertyValue
Melting Point250°C
Boiling PointNot Available
Solubility395 mg/L
Predicted Properties
PropertyValueSource
Water Solubility7.47 g/LALOGPS
logP0.16ALOGPS
logP-0.067ChemAxon
logS-1.5ALOGPS
pKa (Strongest Acidic)0.62ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area115.06 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity38.21 m³·mol⁻¹ChemAxon
Polarizability15.3 ųChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Spectra
Spectra
Spectrum TypeDescriptionSplash KeyView
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positivesplash10-001i-9040000000-af3c2e18902e147f8d42Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, PositiveNot AvailableSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-0006-1190000000-c4ab9891e7e58566d92fSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-03ed-3940000000-c29d8ff76855c0aaef6cSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-001i-9000000000-01a0eea1cf84ed37407aSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-03dl-0950000000-1845236a124e15b5c59bSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-006x-1390000000-3ae475737e6b4b8c7664Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-004i-9000000000-974168c5223d898e9a79Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Positivesplash10-000x-6090000000-8989f8d7643382de70bcSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Positivesplash10-03di-2900000000-95542c15d3d7df8beff2Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Positivesplash10-03ea-4900000000-e088c1d2fe760f01f20dSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, Negativesplash10-00dl-0090000000-125baa903034088b47b6Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, Negativesplash10-00fr-6590000000-8d753c1dbb524b991ddfSpectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, Negativesplash10-00di-1090000000-29462d306ece6e9df24dSpectrum
Toxicity Profile
Route of ExposureOral, Intravenous. After oral administration, absorption is estimated at 1–3% of the ingested dose because of the low uptake from the gastrointestinal tract.
Mechanism of ToxicityThe bisphosphonate group binds strongly to the bone mineral, hydroxyapatite. This explains the specific pharmacological action of these compounds on mineralized tissues, especially bone. The exact mechanism of action of clodronate is not known, however it is known that it does not inhibit protein isoprenylation but can be metabolized intracellularly to a β-γ-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Inhibition of the ADP/ATP translocase by the metabolite AppCCl2p is a likely route by which clodronate causes osteoclast apoptosis and inhibits bone resorption. Recently, the slime mold Dictyostelium discoideum was shown to take up bisphosphonates by pinocytosis. In these cells, clodronate, but not other pharmacologically active bisphosphonates, was incorporated into adenine nucleotides, which could potentially explain why this bisphosphonate sometimes seems to act differently than the other bisphosphonates. Clodronate, like all biphosphonates, also binds protein-tyrosine-phosphatase.
MetabolismClodronate is not metabolized in humans. It can be metabolized intracellularly to a beta-gamma-methylene (AppCp-type) analog of ATP (AppCCl2p), which is cytotoxic to macrophages in vitro. Half Life: Approximately 13 hours.
Toxicity ValuesNot Available
Lethal DoseNot Available
Carcinogenicity (IARC Classification)No indication of carcinogenicity to humans (not listed by IARC).
Uses/SourcesA diphosphonate which affects calcium metabolism. It inhibits bone resorption and soft tissue calcification. For the management of hypercalcemia of malignancy and as an adjunct in the management of osteolysis resulting from bone metastases of malignant tumors.
Minimum Risk LevelNot Available
Health EffectsDecreases in serum calcium following substantial overdosage may be expected in some patients.
SymptomsSigns and symptoms of hypocalcemia also may occur in some of these patients.
TreatmentNot Available
Concentrations
Not Available
DrugBank IDDB00720
HMDB IDHMDB0014858
FooDB IDNot Available
Phenol Explorer IDNot Available
KNApSAcK IDNot Available
BiGG IDNot Available
BioCyc IDNot Available
METLIN IDNot Available
PDB IDNot Available
Wikipedia LinkClodronic acid
Chemspider ID23731
ChEBI ID110423
PubChem Compound ID25419
Kegg Compound IDNot Available
YMDB IDNot Available
ECMDB IDNot Available
References
Synthesis Reference

Fritz Demmer, Berthold Stemmle, “Clodronate-containing medicaments and a process for the preparation thereof.” U.S. Patent US4859472, issued September, 1980.

MSDSLink
General References
1. https://www.ncbi.nlm.nih.gov/pubmed/?term=15658873
2. https://www.ncbi.nlm.nih.gov/pubmed/?term=7818726
3. https://www.ncbi.nlm.nih.gov/pubmed/?term=8421279